That a bank manager, of all people, could be fooled on a scale sufficient to bring down a bank is a sign of how sophisticated ...

We recently published an article titled Jim Cramer’s Game Plan: 15 Stocks in Focus. In this article, we are going to take a ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

The North Chicago-based drugmaker is relying on newer treatments to make up for falling sales of Humira, its aging ...

We recently compiled a list of the Blackrock’s 30 Most Important AI Stocks. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against the other ...

A Hunt Valley drug manufacturing company with more than 300 employees has been acquired by a Fortune 500 firm.

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...